• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卤代三唑硫代乙酰胺作为开发金属β-内酰胺酶抑制剂的有效骨架。

Halogen-Substituted Triazolethioacetamides as a Potent Skeleton for the Development of Metallo-β-Lactamase Inhibitors.

机构信息

College of Biology Pharmacy and Food Engineering, Shangluo University, Shangluo 726000, China.

Key Laboratory of Synthetic and Natural Functional Molecule Chemistry of Ministry of Education, College of Chemistry and Materials Science, Northwest University, Xi'an 710127, China.

出版信息

Molecules. 2019 Mar 25;24(6):1174. doi: 10.3390/molecules24061174.

DOI:10.3390/molecules24061174
PMID:30934584
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6471427/
Abstract

Metallo-β-lactamases (MβLs) are the target enzymes of β-lactam antibiotic resistance, and there are no effective inhibitors against MβLs available for clinic so far. In this study, thirteen halogen-substituted triazolethioacetamides were designed and synthesized as a potent skeleton of MβLs inhibitors. All the compounds displayed inhibitory activity against ImiS with an IC value range of 0.032⁻15.64 μM except . The chlorine substituted compounds (, and ) inhibited NDM-1 with an IC value of less than 0.96 μM, and the fluorine substituted and inhibited VIM-2 with IC values of 38.9 and 2.8 μM, respectively. However, none of the triazolethioacetamides exhibited activity against L1 at inhibitor concentrations of up to 1 mM. Enzyme inhibition kinetics revealed that and are mixed inhibitors for ImiS with values of 0.074 and 0.27μM using imipenem as the substrate. Docking studies showed that and , which have the highest inhibitory activity against ImiS, fit the binding site of CphA as a replacement of ImiS via stable interactions between the triazole group bridging ASP120 and hydroxyl group bridging ASN233.

摘要

金属β-内酰胺酶(MβLs)是β-内酰胺类抗生素耐药性的靶酶,迄今为止,临床上还没有针对 MβLs 的有效抑制剂。在本研究中,设计并合成了 13 种卤代三唑硫代乙酰胺作为 MβLs 抑制剂的有效骨架。除 外,所有化合物均显示出对 ImiS 的抑制活性,IC 值范围为 0.032⁻15.64 μM。氯取代化合物(、和)对 NDM-1 的抑制作用的 IC 值均小于 0.96 μM,氟取代化合物 和 对 VIM-2 的抑制作用的 IC 值分别为 38.9 和 2.8 μM。然而,在抑制剂浓度高达 1 mM 的情况下,没有一种三唑硫代乙酰胺对 L1 表现出活性。酶抑制动力学研究表明,化合物 和 是 ImiS 的混合抑制剂,以亚胺培南为底物时, 值分别为 0.074 和 0.27μM。对接研究表明,对 ImiS 抑制活性最高的化合物 和 ,通过三唑基团桥接 ASP120 和羟基桥接 ASN233 与 CphA 的结合位点稳定相互作用,可作为 ImiS 的替代物结合。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecb2/6471427/db4a07998b27/molecules-24-01174-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecb2/6471427/ff7b4e39ecf0/molecules-24-01174-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecb2/6471427/31cd34363210/molecules-24-01174-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecb2/6471427/092b33ff3a38/molecules-24-01174-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecb2/6471427/db4a07998b27/molecules-24-01174-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecb2/6471427/ff7b4e39ecf0/molecules-24-01174-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecb2/6471427/31cd34363210/molecules-24-01174-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecb2/6471427/092b33ff3a38/molecules-24-01174-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecb2/6471427/db4a07998b27/molecules-24-01174-g003.jpg

相似文献

1
Halogen-Substituted Triazolethioacetamides as a Potent Skeleton for the Development of Metallo-β-Lactamase Inhibitors.卤代三唑硫代乙酰胺作为开发金属β-内酰胺酶抑制剂的有效骨架。
Molecules. 2019 Mar 25;24(6):1174. doi: 10.3390/molecules24061174.
2
Azolylthioacetamides as a potent scaffold for the development of metallo-β-lactamase inhibitors.唑硫基乙酰胺作为开发金属β-内酰胺酶抑制剂的有效骨架。
Bioorg Med Chem Lett. 2017 Dec 1;27(23):5225-5229. doi: 10.1016/j.bmcl.2017.10.038. Epub 2017 Oct 20.
3
Dithiocarbamate as a Valuable Scaffold for the Inhibition of Metallo-β-Lactmases.二硫代氨基甲酸盐作为抑制金属β-内酰胺酶的有价值的支架。
Biomolecules. 2019 Nov 5;9(11):699. doi: 10.3390/biom9110699.
4
Dihydroxyphenyl-substituted thiosemicarbazone: A potent scaffold for the development of metallo-β-lactamases inhibitors and antimicrobial.二羟基苯基取代的硫代半卡巴腙:一种用于开发金属β-内酰胺酶抑制剂和抗菌剂的有效骨架。
Bioorg Chem. 2022 Oct;127:105928. doi: 10.1016/j.bioorg.2022.105928. Epub 2022 Jun 13.
5
Dipyridyl-substituted thiosemicarbazone as a potent broad-spectrum inhibitor of metallo-β-lactamases.二吡啶基取代的硫代缩氨基脲作为一种有效的广谱金属-β-内酰胺酶抑制剂。
Bioorg Med Chem. 2021 May 15;38:116128. doi: 10.1016/j.bmc.2021.116128. Epub 2021 Apr 8.
6
Hydroxamic acid with benzenesulfonamide: An effective scaffold for the development of broad-spectrum metallo-β-lactamase inhibitors.羟肟酸与苯磺酰胺:开发广谱金属β-内酰胺酶抑制剂的有效支架。
Bioorg Chem. 2020 Dec;105:104436. doi: 10.1016/j.bioorg.2020.104436. Epub 2020 Oct 29.
7
The assemblage of covalent and metal binding dual functional scaffold for cross-class metallo-β-lactamases inhibition.用于交叉类金属β-内酰胺酶抑制的共价和金属结合双重功能支架的组装。
Future Med Chem. 2019 Sep;11(18):2381-2394. doi: 10.4155/fmc-2019-0008. Epub 2019 Sep 23.
8
Amino Acid Thioesters Exhibit Inhibitory Activity against B1-B3 Subclasses of Metallo-β-lactamases.氨基酸硫酯对金属β-内酰胺酶的B1-B3亚类具有抑制活性。
Chem Pharm Bull (Tokyo). 2019;67(2):135-142. doi: 10.1248/cpb.c18-00717.
9
Diaryl-substituted azolylthioacetamides: Inhibitor discovery of New Delhi metallo-β-lactamase-1 (NDM-1).二芳基取代的唑基硫代乙酰胺:新型德里金属β-内酰胺酶-1(NDM-1)抑制剂的发现
ChemMedChem. 2014 Nov;9(11):2445-8. doi: 10.1002/cmdc.201402249. Epub 2014 Jul 22.
10
Triazolylthioacetamide: A Valid Scaffold for the Development of New Delhi Metallo-β-Lactmase-1 (NDM-1) Inhibitors.三唑基硫代乙酰胺:一种开发新型德里金属β-内酰胺酶-1(NDM-1)抑制剂的有效骨架。
ACS Med Chem Lett. 2016 Feb 16;7(4):413-7. doi: 10.1021/acsmedchemlett.5b00495. eCollection 2016 Apr 14.

引用本文的文献

1
Approachable Synthetic Methodologies for Second-Generation -Lactamase Inhibitors: A Review.第二代β-内酰胺酶抑制剂的便捷合成方法:综述
Pharmaceuticals (Basel). 2024 Aug 23;17(9):1108. doi: 10.3390/ph17091108.
2
Boronic Acids as Prospective Inhibitors of Metallo-β-Lactamases: Efficient Chemical Reaction in the Enzymatic Active Site Revealed by Molecular Modeling.硼酸作为金属β-内酰胺酶抑制剂的研究进展:分子模拟揭示酶活性部位的高效化学反应。
Molecules. 2021 Apr 2;26(7):2026. doi: 10.3390/molecules26072026.
3
Binding of 2-(Triazolylthio)acetamides to Metallo-β-lactamase CcrA Determined with NMR.

本文引用的文献

1
Interplay between β-lactamases and new β-lactamase inhibitors.β-内酰胺酶与新型β-内酰胺酶抑制剂的相互作用。
Nat Rev Microbiol. 2019 May;17(5):295-306. doi: 10.1038/s41579-019-0159-8.
2
Past and Present Perspectives on β-Lactamases.β-内酰胺酶的过去与现在观点。
Antimicrob Agents Chemother. 2018 Sep 24;62(10). doi: 10.1128/AAC.01076-18. Print 2018 Oct.
3
Molecular and computational approaches to understand resistance of New Delhi metallo β-lactamase variants (NDM-1, NDM-4, NDM-5, NDM-6, NDM-7)-producing strains against carbapenems.
利用核磁共振确定2-(三唑基硫代)乙酰胺与金属β-内酰胺酶CcrA的结合情况。
ACS Omega. 2020 Aug 18;5(34):21570-21578. doi: 10.1021/acsomega.0c02187. eCollection 2020 Sep 1.
4
Synthesis and Bioactivity of Thiazolethioacetamides as Potential Metallo-β-Lactamase Inhibitors.噻唑硫代乙酰胺作为潜在金属β-内酰胺酶抑制剂的合成及生物活性
Antibiotics (Basel). 2020 Feb 26;9(3):99. doi: 10.3390/antibiotics9030099.
采用分子和计算方法了解产生新德里金属β-内酰胺酶变体(NDM-1、NDM-4、NDM-5、NDM-6、NDM-7)的菌株对碳青霉烯类抗生素耐药的机制。
J Biomol Struct Dyn. 2019 May;37(8):2061-2071. doi: 10.1080/07391102.2018.1475261. Epub 2018 Dec 5.
4
The Continuing Challenge of Metallo-β-Lactamase Inhibition: Mechanism Matters.金属β-内酰胺酶抑制的持续挑战:机制至关重要。
Trends Pharmacol Sci. 2018 Jul;39(7):635-647. doi: 10.1016/j.tips.2018.03.007. Epub 2018 Apr 18.
5
An update on β-lactamase inhibitor discovery and development.β-内酰胺酶抑制剂的发现和发展研究进展
Drug Resist Updat. 2018 Jan;36:13-29. doi: 10.1016/j.drup.2017.11.002. Epub 2017 Nov 7.
6
NDM-1 encoded by a pNDM-HN380-like plasmid pNDM-BJ03 in clinical Enterobacter cloacae.临床阴沟肠杆菌中由类似pNDM-HN380的质粒pNDM-BJ03编码的NDM-1。
Diagn Microbiol Infect Dis. 2018 Feb;90(2):153-155. doi: 10.1016/j.diagmicrobio.2017.10.022. Epub 2017 Nov 7.
7
Azolylthioacetamides as a potent scaffold for the development of metallo-β-lactamase inhibitors.唑硫基乙酰胺作为开发金属β-内酰胺酶抑制剂的有效骨架。
Bioorg Med Chem Lett. 2017 Dec 1;27(23):5225-5229. doi: 10.1016/j.bmcl.2017.10.038. Epub 2017 Oct 20.
8
Extended infusion of beta-lactam antibiotics: optimizing therapy in critically-ill patients in the era of antimicrobial resistance.β-内酰胺类抗生素的延长输注:在抗微生物药物耐药时代优化危重症患者的治疗。
Expert Rev Anti Infect Ther. 2017 Jul;15(7):645-652. doi: 10.1080/14787210.2017.1348894. Epub 2017 Jul 3.
9
WCK 5107 (Zidebactam) and WCK 5153 Are Novel Inhibitors of PBP2 Showing Potent "β-Lactam Enhancer" Activity against Pseudomonas aeruginosa, Including Multidrug-Resistant Metallo-β-Lactamase-Producing High-Risk Clones.WCK 5107(齐德巴坦)和WCK 5153是新型PBP2抑制剂,对铜绿假单胞菌表现出强大的“β-内酰胺增强剂”活性,包括产多重耐药金属β-内酰胺酶的高风险克隆株。
Antimicrob Agents Chemother. 2017 May 24;61(6). doi: 10.1128/AAC.02529-16. Print 2017 Jun.
10
Zinc ion-induced conformational changes in new Delphi metallo-β-lactamase 1 probed by molecular dynamics simulations and umbrella sampling.通过分子动力学模拟和伞形抽样探究锌离子诱导的新型德尔菲金属β-内酰胺酶1的构象变化
Phys Chem Chem Phys. 2017 Jan 25;19(4):3067-3075. doi: 10.1039/c6cp08105c.